Your Article Summary
Refractory Neovascular Age-related Macular Degeneration Secondary to Polypoidal Choroidal Vasculopathy
American Journal of Ophthalmology, 06/26/09
Cho M et al. - Treatment-refractory neovascular AMD may harbor vascular abnormalities such as PCV. Modifications in therapeutic protocols may be indicated in order to improve visual and anatomic outcomes in this population.
Related Articles
A 1-Year Retrospective Review of Ranibizumab for Naive Nonsubfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
Retina, 11/25/09
Relevance Score: 68%
Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration
Retina, 11/11/09
Relevance Score: 68%
Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial
Ophthalmology, 10/28/09
Relevance Score: 68%
siRNA therapeutics for age-related macular degeneration: promises and pitfalls
Expert Review of Ophthalmology, 10/22/09
Relevance Score: 68%
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Relevance Score: 67%
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Cataract surgery after pars plana vitrectomy
Current Opinion in Ophthalmology, 12/16/09
The effects of intravitreally injected bevacizumab on the retina and retina pigment epithelium: experimental in-vivo electron microscopic study in intact versus vitrectomized eyes
Central European Journal of Medicine, 12/16/09
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09

See Latest Articles